New study tracks rare urinary cancers to unlock better treatments

NCT ID NCT04923178

First seen Nov 12, 2025 · Last updated Jun 15, 2026 · Updated 30 times

Summary

This study follows people with common and rare urinary tract cancers (like bladder, kidney, and testicular) to understand how these cancers behave over time. Researchers will collect medical records, blood, urine, and tumor samples to track disease progression and treatment responses. The goal is to gather information that can help improve future care for these cancers. Participants will receive recommendations for managing their cancer and will be followed for life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.